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Aim To assess iodine supply and follow thyroid epidemiol-
ogy for ten years after an iodine increase from 10 to 25 mg 
of potassium iodide per kilogram of salt in 1999.
Methods In 2002 and 2003, we determined the thyroid 
size by palpation and ultrasound and measured urinary 
iodine concentration (UIC) in 676 schoolchildren from 34 
schools throughout Slovenia. From 1999 to 2009, we fol-
lowed the incidence of diffuse and nodular goiter, thyroid 
autonomy, Graves’ disease, and Hashimoto’s thyroiditis 
among adults in the stable catchment area of the Univer-
sity Medical Centre Ljubljana with 1 000 000 inhabitants.
Results In children, only 1% had a goiter grade 2 (visible 
and palpable thyroid gland), median thyroid volume was 
5.8 mL, and median UIC was 148 µg/L. In adults, the inci-
dence of diffuse goiter and thyroid autonomy decreased 
significantly (2009 vs 1999, rate ratio [RR], 0.16; 95% con-
fidence interval [CI], 0.12-0.21 and RR, 0.73; 95% CI, 0.62-
0.86, respectively), with a lower incidence in younger par-
ticipants in 2009 (P < 0.001). The incidence of multinodular 
goiter and solitary nodule increased (2009 vs 1999, RR, 1.55; 
95% CI, 1.35-1.79 and RR, 1.72; 95% CI, 1.49-1.99, respective-
ly). No long-term changes were observed for Graves’ dis-
ease (2009 vs 1999, RR, 0.95; 95% CI, 0.81-1.13), while the in-
cidence of Hashimoto’s thyroiditis increased strongly (2009 
vs 1999, RR, 1.86; 95% CI, 1.64-2.12).
Conclusions The change from mildly deficient to suffi-
cient iodine supply was associated with a marked change 
in the incidence of thyroid epidemiology – a significant de-
cline in the incidence of diffuse goiter and thyroid autono-
my and a marked increase in the incidence of Hashimoto’s 
thyroiditis.
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Iodine is an essential element of thyroid hormones and its 
sufficient intake is crucial for the prevention of iodine de-
ficiency disorders. Iodine supplementation is an important 
public health measure that influences the thyroid volume 
and determines the epidemiology of thyroid disorders. Ac-
cording to the World Health Organization (WHO) criteria, the 
main indicators of iodine supply are median urinary iodine 
concentration (UIC) and thyroid size in schoolchildren (1).
There are limited and sometimes conflicting longitudinal 
studies on epidemiology of thyroid disorders after the in-
crease in iodine intake in areas with previously mild iodine 
deficiency. A few studies reported an early increase in the in-
cidence of hyperthyroidism due to Graves’ disease and thy-
roid autonomy (2-4), in some cases followed by a decrease 
(2,5). Some reported an increased incidence of hypothyroid-
ism (5), probably due to a higher incidence of thyroid au-
toimmunity (6-8). All investigators observed a decrease in 
the incidence of diffuse goiter in young population (3,9-11), 
while the data in the elderly are controversial (3,12).
The prevalence of goiter in Slovenia between the two 
world wars was up to 80% (13). In 1953, iodine prophylaxis 
was introduced with addition of 10 mg potassium iodide 
per kilogram of kitchen salt. In 1991 to 1994, an epidemio-
logical study revealed a goiter grade 2 by WHO criteria in 
11% of 1740 schoolchildren aged 13 years (14). The mean 
thyroid volume measured by ultrasonography was 7.2 mL 
and UIC was lower than 100 μg/g of creatinine in 73.7% 
of children, with a median of 82.9 μg/g of creatinine (14), 
which classified Slovenia a mildly iodine-deficient accord-
ing to the WHO criteria. Therefore, in January 1999 the Min-
istry of Health issued a recommendation for mandatory 
salt iodization with 25 mg (within range of 20-30 mg) of 
potassium iodide.
In this study, we investigated the iodine supply and inci-
dence of different thyroid disorders in Slovenia after the 
increase in salt iodization in 1999. We assessed the iodine 
supply in a population of schoolchildren using UIC and 
measurement of thyroid volume. We also performed a ten-
year follow-up on the incidence of different thyroid disor-
ders, including goiter, thyroid autonomy, Graves’ disease, 
and Hashimoto’s thyroiditis in the adult population.
ParticiPantS and mEtHodS
Schoolchildren study
In the epidemiological study conducted in 2002 and 
2003, we included 676 schoolchildren aged 13 years, 
343 girls and 333 boys, from the same 34 public elementa-
ry schools as the study conducted in 1991 to 1994 (14). At 
that time, schools were selected from all regions through-
out Slovenia considering the number of 13-year olds in 
each region. In every school, one class of schoolchildren of 
appropriate age was included. We determined the size of 
their thyroid gland by inspection and palpation, separately 
by two independent expert examiners according to WHO 
criteria: grade 0 (not visible, not palpable thyroid gland), 
grade 1A (not visible, palpable thyroid gland), 1B (visible at 
the extended neck position, palpable thyroid gland), 2 (vis-
ible at the normal neck position, palpable thyroid gland). 
Thyroid volume was measured using an Aloka SSD-900 ul-
trasound with 5 MHz probe and Brunn’s formula (15). UIC 
was measured using commercially available kit (Urinary io-
dine assay kit, Bioclone Australia Pty Limited, Sydney, Aus-
tralia), based on the improved Sandell-Kolthoff reaction, 
and samples were digested with ammonium persulphate 
on microtiter plate by specially designed sealing cassette. 
UIC was expressed in microgram per liter. The study was 
approved by the National Medical Ethics Committee and 
the participants signed a written informed consent prior 
to enrolment in the study.
identification of new cases of thyroid disorders in adult 
Slovenian population
We consecutively examined adult patients referred for 
the first time to the Thyroid Department at the University 
Medical Centre Ljubljana. It is the only institution with thy-
roid specialists and with facilities for thyroid scintigraphy in 
the area, covering a half of Slovenia. This catchment area 
with approximately 1 million inhabitants has remained un-
changed for more than 20 years. Patients were referred by 
general practitioners under the suspicion of thyroid dys-
function or goiter. Each patient was examined by one out 
of six thyroid specialists working at this department. We 
continuously identified all new cases of different thyroid 
disorders. The data in the period from January 1, 1999 to 
December 31, 2009 were obtained from the computer-
based register of the Department of Nuclear Medicine.
diagnostics of thyroid disorders
All patients were clinically examined. We measured thyrotro-
pin (TSH), free thyroxine (T
4), free triiodothyronine (T3), thy-
roid peroxidase antibodies (TPOAb), and thyroglobulin an-
tibodies (TgAb), and performed thyroid ultrasound. Diffuse 
and nodular goiter was diagnosed on the basis of ultrasound 
picture, while thyroid function was normal and TPOAb and 
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TgAb were negative. Patients with nodular goiter present-
ed either with multinodular goiter or with solitary nodule. 
Thyroid autonomy was diagnosed by biochemical hyper-
thyroidism and thyroid scintigraphy with 99m-pertechne-
tate and patients were negative for TSH receptor antibodies 
(TSHRAb). Patients with Graves’ disease were hyperthyroid 
and positive for TSHRAb, while patients with Hashimoto’s 
thyroiditis presented with different thyroid function and 
elevated TPOAb and/or TgAb. In both, ultrasound showed 
characteristic hypoechoic picture. Hypothyroid Hashimoto’s 
thyroiditis patients presented with elevated TSH and normal 
or decreased free thyroid hormones.
Statistics
Statistical analysis was performed with the Statistica soft-
ware (StatSoft, Tulsa, OK, USA). Goiter volume and UIC in 
schoolchildren were expressed with median values. The 
correlation between thyroid size estimated by palpation 
and thyroid volume was calculated using Spearman cor-
relation test.
The incidence rates were evaluated using rate ratios (RR) 
with baseline value in 1999 and 95% confidence intervals 
(CI), calculated after log transformation of the respective 
rates. Calculations were made assuming the Poisson dis-
tribution of cases (http://www.quantitativeskills.com/sisa/
statistics). We compared the age of patients with different 
thyroid diseases in the year of the increase in iodine intake 
(year 1999) and ten years later (year 2009). The selection 
of these two years was based on our assumption and on 
previous observations (2,16) that more than five years was 
necessary for the stabilization of the epidemiological situ-
ation after such an increase in iodine supply. Ages were 
expressed as medians and range. Groups were compared 
using Mann-Whitney U test. P value below 0.05 was con-
sidered significant.
rESultS
There were 53% of children with thyroid gland grade 0, 28% 
with 1A, 18% with 1B, and only 1% with grade 2 (Figure 1). 
Median thyroid volume measured by ultrasound was 5.8 
mL (range, 1.9-30.3 mL); in girls 5.9 mL (range, 2.2-24.2 mL) 
and in boys 5.7 mL (1.9-30.3 mL). Median UIC was 148 µg/L 
(range, 2-1744 µg/L); in girls 148 µg/L (range, 6-1744 µg/L) 
and in boys 148 µg/L (range, 2-741 µg/L). Median UIC was 
below 100 µg/L in only 22% of children (Figure 2). The cor-
relation between the results of palpation and thyroid vol-
ume was significant (r = 0.46, P < 0.001).
After the increase in iodine intake, the incidence of dif-
fuse goiter in adult Slovenian population gradually de-
creased from 35.3/100 000 in 1999 to more than an 80% 
lower value in 2009 (vs baseline, RR, 0.16; 95% CI, 0.12-0.21) 
(Figure 3A). Patients with diffuse goiter were significantly 
older in 2009 than in 1999 (Table 1). The incidence of mul-
tinodular goiter and solitary nodules was 32.7/100 000 and 
28.6/100 000, respectively, in 1999 but during the last five 
years until 2009 it slowly increased to 55% and 72% higher 
levels, respectively (RR, 1.55; 95% CI, 1.35-1.79 and RR, 1.72; 
95% CI, 1.49-1.99, respectively) (Figure 3B and 3C). In both 
Figure 1.
thyroid size in 676 schoolchildren after the increase in iodine intake in 
Slovenia estimated by inspection and palpation. Grade 0 (not visible, not 
palpable thyroid gland), grade 1a (not visible, palpable thyroid gland), 
1B (visible at the extended neck position, palpable thyroid gland), 2 (vis-
ible at the normal neck position, palpable thyroid gland). closed bars – 
all children, gray bars – boys, open bars – girls.
Figure 2.
urinary iodine concentration in 676 schoolchildren after the increase in 
iodine intake in Slovenia. as indicated in the figure, 22% of schoolchil-
dren had urinary iodine concentration below 100 μg/l.
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diseases, there was no significant difference in the age of 
patients before and after the iodine increase (Table 1).
The baseline incidence of thyroid autonomy was 32.7/100 000 
and by 2009 it gradually and significantly decreased to a 
27% lower value (RR, 0.73; 95% CI, 0.62-0.86) (Figure 3D). Pa-
tients with thyroid autonomy were significantly older than 
other thyroid patients (P < 0.001). Interestingly, in 2009, the 
median age of newly diagnosed thyroid autonomy patients 
was significantly higher than in 1999 (Table 1).
The baseline incidence of Graves’ disease was 27.8/100 000 
and it did not change significantly until 2005, when we in-
troduced a more sensitive second generation TSH receptor 
antibody assay. However, in 2009 the incidence decreased 
to the baseline level (vs baseline, RR, 0.95; 95% CI, 0.81-1.13) 
(Figure 3E). The age of patients with Graves’ disease did not 
change significantly (Table 1).
The baseline incidence of Hashimoto’s thyroiditis was 
73.2/100 000 and it gradually increased during the first 
eight years to the levels more than twice as high as before. 
Since 2006, the incidence remained stable, with a rate of 
166.4/100 000 in 2009 (vs baseline, RR, 2.27; 95% CI, 2.08-
2.48). The observation was similar in patients with hypo-
thyroid Hashimoto’s thyroiditis, the incidence of which was 
Figure 3.
the rate ratio of thyroid diseases incidence in the period from 2000 to 2009 vs baseline in 1999, the year when the increased salt iodization was introduced. 
95% confidence intervals of the rate are indicated by vertical bars. the data refer to diffuse goiter (A), multinodular goiter (B), solitary nodule (C), thyroid 
autonomy (D), Graves’ disease (E), and Hashimoto’s thyroiditis (F) where hypothyroid patients are shown with gray line. in Figures E and D, the pointer indi-
cates the introduction of a new (second) generation of the thyrotropin receptor antibody assay. arrows indicate intruduction of new method.
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36.9/100 000 in 1999 and 68.8/100 000 in 2009 (vs baseline, 
RR, 1.86; 95% CI, 1.64-2.12) (Figure 3F). The age of patients 
with Hashimoto’s thyroiditis was similar in 2009 and 1999, 
and in both periods hypothyroid patients were significant-
ly older at the disease presentation than patients with eu-
thyroid Hashimoto’s thyroiditis (P < 0.001) (Table 1). In spite 
of a marked increase in Hashimoto’s thyroiditis incidence, 
the proportion of patients with hypothyroid Hashimoto’s 
thyroiditis was significantly lower than the proportion of 
those with non-hypothyroid Hashimoto’s thyroiditis in 
2009 than in 1999 (χ2 = 16.57, P < 0.001).
diScuSSion
The present study confirmed that after the increase in 
salt iodization in Slovenia there was an adequate iodine 
supply, with a median UIC in schoolchildren of 148 µg/L 
and a prevalence of goiter below 1%. The ten-year follow-
up showed a marked change in thyroid epidemiology in 
adults, with a gradual decrease in the incidence of diffuse 
goiter and thyroid autonomy, an increase in the incidence 
of Hashimoto’s thyroiditis and nodular goiter, but only a 
transient increase in the incidence of Graves’ disease. Al-
though the incidence was estimated on the basis of new 
cases registered in thyroid department, which might be 
considered a limitation, we believe that a very large and 
stable catchment area enabled us an excellent approxima-
tion of the real incidence.
This study showed that according to WHO criteria Slo-
venia was an iodine-sufficient area in terms of UIC, thy-
roid size, and goiter prevalence in schoolchildren (1). We 
consider median UIC to be adequate, although we were 
not able to make a precise comparison with our previ-
ous study (14), conducted from 1991 to 1994, since the 
measure of UIC in that study was iodine per gram of crea-
tinine, while in this study it was iodine per liter of urine. 
The experience in the last decade showed that the latter 
was a better measure of iodine supply in schoolchildren 
(17). We were able to compare the thyroid volume, which 
significantly decreased from 7.2 mL to 5.8 mL (14). Oth-
er reports on schoolchildren following improved iodine 
supply have observed a decreased goiter prevalence 
(10,11,18,19).
The reports on goiter in adults are limited and conflicting. 
Our data showed a significantly lower incidence of diffuse 
goiter after improved iodization, which is in accordance 
with a Danish observational study (12), as well as with two 
interventional studies that showed a significant decrease 
in thyroid volume in patients with euthyroid diffuse goiter 
(20,21). In a small group of Swiss patients, no change in 
thyroid volume before and after the increase in iodine sup-
plementation has been observed (22). In iodine-sufficient 
Austrian population, a small cross-sectional study revealed 
a higher prevalence of both diffuse and multinodular goi-
ter in the age group older than 40 years (3). Similar is our 
observation that patients diagnosed with diffuse goiter 
were significantly older ten years after increased iodization, 
which indicates that there is a decrease in the incidence of 
diffuse goiter in the younger population. We found an in-
creasing incidence of nodular goiter after increased iodiza-
tion, as opposed to a study on Danish population (12). We 
have no scientific explanation for such a finding but we 
believe that this phenomenon probably is not associated 
with iodine supplementation but is a reflection of more 
neck ultrasounds performed in Slovenia in the last five 
years. However, despite more frequently diagnosed 
taBlE 1. age of patients with different thyroid diseases after the increase in salt iodization in Slovenia in 1999 from 10 to 25 mg 




in years (range) number
median age 
in years (range) P*
Diffuse goiter 353 38 (14-84)   56 53 (16-88) <0.001
Multinodular goiter 327 59 (18-92)  508 60 (15-93)  0.058
Solitary nodule 286 48 (15-90)  492 50 (15-89)  0.861
Thyroid autonomy 327 69 (19-91)  239 72 (27-92) <0.001
Graves’ disease 278 41 (15-78)  265 44 (16-82)  0.101
Hashimoto’s thyroiditis (HT), total 732 51 (16-89) 1664 50 (15-97)  0.211
Non-hypothyroid HT† 363 48 (16-88)  976 48 (15-88)  0.629
Hypothyroid HT† 369 54 (18-89)  688 54 (15-97)  0.797
*mann-Whitney u test.
†P < 0.001 when comparing age of non-hypothyroid and hypothyroid Ht patients.
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nodular goiter, there was a decrease in the incidence of 
highly malignant thyroid carcinoma (23).
The data on the incidence of thyroid autonomy after in-
creased iodization are scarce. While the reports from Swit-
zerland and Austria indicate a short-term increase (2,16,24), 
we observed a significant decrease already in the first year 
after increased iodization. Such finding is in line with in-
vestigations carried out in Switzerland (2,16). Both our and 
Austrian data show that after the increase in iodine intake, 
there were more thyroid autonomy patients belonging to 
an older age-group. One might assume that a long-term 
sufficient iodine intake reduces the occurrence of goiter 
and thyroid autonomy especially in younger population, 
which might explain the older age of thyroid autonomy 
patients in 2009.
The incidence of Graves’ disease did not change consid-
erably during the 10-year follow-up, which does not con-
firm the results of other studies. In Switzerland, the ini-
tial increase in incidence was followed by a decrease to 
a level lower than before the increased iodization (2,16). 
In Austrian population, the Graves’ disease incidence was 
still high 5 years after increased iodization (24). The differ-
ences in Graves’ disease incidence might be influenced 
by different observation periods and by differences in di-
agnostics caused by evolution of TSH receptor antibody 
assay.
A large epidemiological study has reported a high inci-
dence of thyroid antibodies and hypothyroidism in area 
with adequate iodine intake (25). These data are in accor-
dance with our study, as well as with several other studies 
in which the incidence of thyroid antibodies and the prev-
alence of hypothyroidism increased after the increase in 
iodization (3,5,19,26-28). The same age of affected partici-
pants before and after iodine increase indicates the impor-
tance of genetic background, while the disease is equally 
accelerated by iodine in all age groups.
In conclusion, in an iodine-sufficient area of Slovenia, the 
change from mildly deficient to sufficient iodine supply re-
sulted in a long-term change in thyroid disease pattern. A 
significant decrease in diffuse goiter and thyroid autono-
my, predominantly in younger population, indicates the 
protective role of adequate iodine intake in their patho-
genesis. The increased incidence of Hashimoto’s thyroidi-
tis in all age groups also confirms that increase in iodine 
intake strengthens thyroid autoimmunity regardless of 
age, probably in genetically predisposed individuals.
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